Literature DB >> 24921542

A 3D integral imaging optical see-through head-mounted display.

Hong Hua, Bahram Javidi.   

Abstract

An optical see-through head-mounted display (OST-HMD), which enables optical superposition of digital information onto the direct view of the physical world and maintains see-through vision to the real world, is a vital component in an augmented reality (AR) system. A key limitation of the state-of-the-art OST-HMD technology is the well-known accommodation-convergence mismatch problem caused by the fact that the image source in most of the existing AR displays is a 2D flat surface located at a fixed distance from the eye. In this paper, we present an innovative approach to OST-HMD designs by combining the recent advancement of freeform optical technology and microscopic integral imaging (micro-InI) method. A micro-InI unit creates a 3D image source for HMD viewing optics, instead of a typical 2D display surface, by reconstructing a miniature 3D scene from a large number of perspective images of the scene. By taking advantage of the emerging freeform optical technology, our approach will result in compact, lightweight, goggle-style AR display that is potentially less vulnerable to the accommodation-convergence discrepancy problem and visual fatigue. A proof-of-concept prototype system is demonstrated, which offers a goggle-like compact form factor, non-obstructive see-through field of view, and true 3D virtual display.

Entities:  

Year:  2014        PMID: 24921542     DOI: 10.1364/OE.22.013484

Source DB:  PubMed          Journal:  Opt Express        ISSN: 1094-4087            Impact factor:   3.894


  9 in total

1.  FIMic: design for ultimate 3D-integral microscopy of in-vivo biological samples.

Authors:  G Scrofani; J Sola-Pikabea; A Llavador; E Sanchez-Ortiga; J C Barreiro; G Saavedra; J Garcia-Sucerquia; M Martínez-Corral
Journal:  Biomed Opt Express       Date:  2017-12-22       Impact factor: 3.732

2.  Toward the next-generation VR/AR optics: a review of holographic near-eye displays from a human-centric perspective.

Authors:  Chenliang Chang; Kiseung Bang; Gordon Wetzstein; Byoungho Lee; Liang Gao
Journal:  Optica       Date:  2020-11-20       Impact factor: 11.104

3.  Smartphone- versus smartglasses-based augmented reality (AR) for percutaneous needle interventions: system accuracy and feasibility study.

Authors:  Ming Li; Reza Seifabadi; Dilara Long; Quirina De Ruiter; Nicole Varble; Rachel Hecht; Ayele H Negussie; Venkatesh Krishnasamy; Sheng Xu; Bradford J Wood
Journal:  Int J Comput Assist Radiol Surg       Date:  2020-07-30       Impact factor: 2.924

4.  See-through optical combiner for augmented reality head-mounted display: index-matched anisotropic crystal lens.

Authors:  Jong-Young Hong; Chang-Kun Lee; Seungjae Lee; Byounghyo Lee; Dongheon Yoo; Changwon Jang; Jonghyun Kim; Jinsoo Jeong; Byoungho Lee
Journal:  Sci Rep       Date:  2017-06-05       Impact factor: 4.379

5.  Augmented reality near-eye display using Pancharatnam-Berry phase lenses.

Authors:  Seokil Moon; Chang-Kun Lee; Seung-Woo Nam; Changwon Jang; Gun-Yeal Lee; Wontaek Seo; Geeyoung Sung; Hong-Seok Lee; Byoungho Lee
Journal:  Sci Rep       Date:  2019-04-29       Impact factor: 4.379

6.  All-passive transformable optical mapping near-eye display.

Authors:  Wei Cui; Liang Gao
Journal:  Sci Rep       Date:  2019-04-15       Impact factor: 4.379

7.  Phase-modulating lasers toward on-chip integration.

Authors:  Yoshitaka Kurosaka; Kazuyoshi Hirose; Takahiro Sugiyama; Yu Takiguchi; Yoshiro Nomoto
Journal:  Sci Rep       Date:  2016-07-26       Impact factor: 4.379

8.  Metasurface eyepiece for augmented reality.

Authors:  Gun-Yeal Lee; Jong-Young Hong; SoonHyoung Hwang; Seokil Moon; Hyeokjung Kang; Sohee Jeon; Hwi Kim; Jun-Ho Jeong; Byoungho Lee
Journal:  Nat Commun       Date:  2018-11-01       Impact factor: 14.919

9.  Computational holographic Maxwellian near-eye display with an expanded eyebox.

Authors:  Chenliang Chang; Wei Cui; Jongchan Park; Liang Gao
Journal:  Sci Rep       Date:  2019-12-10       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.